retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Efficacy and safety of retatrutide, a GIP, GLP-1, and receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Retatrutide for weight loss: Study

Description

That plan includes a reduced-calorie diet and consistent movement goals

December 2025: The Judicial Panel on Multidistrict Litigation (JPML) has approved a new group lawsuit for people who experienced vision loss after taking Mounjaro and other GLP-1s

The changing landscape of atherosclerosis

doi:10.1136/bmj.k872

How Eden's program works Most telehealth GLP-1 programs follow a similar structure: (1) patient fills out an intake form including weight, medical history, and medication list